Sleep Disordered Breathing With Opioid Use
Launched by VA OFFICE OF RESEARCH AND DEVELOPMENT · Oct 18, 2022
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how certain treatments can help improve breathing problems during sleep for veterans who use prescription opioids. Opioids, commonly used for pain management, can sometimes lead to serious sleep issues, including a condition called central sleep apnea, where breathing becomes irregular during sleep. The researchers want to see if using oxygen and a medication called acetazolamide can help stabilize breathing and reduce sleep apnea symptoms in these individuals. They will also look at how these issues affect the overall quality of life, sleep, and pain levels in veterans.
To participate in this study, veterans aged 18 to 89 who are currently taking prescription opioids can apply. However, some individuals will not be eligible, including those with severe obesity, certain heart conditions, or significant untreated mental health issues. If you join the trial, you can expect to undergo various assessments to help understand how your sleep and health are affected by opioid use and the treatments being tested. Ultimately, this trial aims to find new ways to improve sleep and health for veterans experiencing these challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Veterans, age 18-89 years
- • Veterans with prescription opioids
- Exclusion Criteria:
- • Patients with BMI\>40kg/m2 will be excluded to avoid the effects of morbid obesity on pulmonary mechanics and ventilatory control
- • Patients with history of unresolved/untreated cardiac disease, including recent myocardial infarction, recent bypass surgery, untreated atrial and ventricular tachy-bradycardias
- • Congestive heart failure with Cheyne-Stokes respiration (CSR)
- • Current unstable angina
- • Recent stroke
- • Untreated schizophrenia
- • Untreated hypothyroidism
- • Unresolved seizure disorder
- • Severe respiratory, neurological, liver and renal diseases
- • Unstable psychiatric disorders/untreated PTSD
- • Traumatic brain injury
- • Pregnant women
- • Significant sleep disorder such as narcolepsy, parasomnias disorder
- • Failure to give informed consent
- • Patients on tramadol and suboxone/buprenorphine
About Va Office Of Research And Development
The VA Office of Research and Development (ORD) is dedicated to advancing the health and well-being of veterans through innovative research initiatives. As a pivotal sponsor of clinical trials, ORD focuses on a broad spectrum of health-related topics, including mental health, rehabilitation, and chronic disease management, ensuring that findings are directly applicable to the unique needs of the veteran population. With a commitment to scientific excellence and collaboration, ORD promotes rigorous study designs and ethical standards, facilitating the translation of research discoveries into improved clinical practices and policies that enhance veteran care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Detroit, Michigan, United States
Detroit, Michigan, United States
Detroit, Michigan, United States
Patients applied
Trial Officials
Susmita Chowdhuri, MD MS
Principal Investigator
John D. Dingell VA Medical Center, Detroit, MI
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials